- Solara Active Pharma Sciences hits 52-week high.
- Patel Engineering launches QIP at Rs 59.50 per share.
- Quant Small Cap Fund picks up stake in Indraprastha Medical.
- Dr Lal Path Labs, Metropolis face competition from new-age diagnostic rivals.
- Persistent Systems shares drop 9% on Q4 miss.
- Mamaearth parent rallies 4% as Derma Co hits Rs 500-cr revenue.
- NTPC signs MoU with Indus Towers for green energy; share price falls.
- HDFC Bank’s Q4 report indicates preference for profitability over growth.
- Gujarat State Petronet shares plunge 20% after tariff cut.
- JSW Energy hits 52-week high after bagging 700-MW solar project.
- Sona BLW Precision stock drops despite new plant in Mexico, North America is key market.
- IREDA zooms 8% as Q4 profit rises 33%, net interest income increased.
- Ultratech Cement shares up 2% on acquisition of grinding unit in Maharashtra.
- Yes Bank shares gain on Rs 284.21-crore tax refund order, board meeting ahead.
- Wipro’s Q4 earnings beat estimates but weak guidance disappoints brokerages.
- Nippon Life AMC’s stock surges on strong growth in AUM.
- Analysts expect volatility to persist as higher US bond yields deter FIIs.
- Canara Bank sets record date for stock split; shares rise 32% in 2024.
- Motilal Oswal to issue bonus shares;
- Bajaj Auto’s Q4 earnings impress despite rich valuations.
- Adani Group releases Rs 26,500 crore pledged shares in FY24.
- Mahindra Lifespace sells Rs 350 crore homes in Bengaluru.
- ITC shares rise on ITC Infotech deal worth Rs 485 crore.
- CONCOR signs MoU with PSA Mesa Supply Chain.
- Infosys Q4 FY24: Disappointing quarter but attractive valuation.
- IndiGo maintains market share despite aircraft grounding.
- Bajaj Auto plans Egypt entry with “Qute” platform despite currency concerns.
- HDFC Life’s Q4 results beat Street; net profit rises 15%.
- Mastek surges 20% on bagging £1.2-billion UK digital and IT services supply order.
- ICICI Lombard sees strong growth with improved profitability in FY24.
- MIT’s investment arm shows interest in Marksans Pharma, boosting small-cap’s potential.
- Nestle India faces steep intraday fall due to high sugar levels in Cerelac.
- Market rebounds; volatility eases, sectors trade positively except FMCG.
- Tata Communications stock rises 56% in one year, re-appoints CEO.
- Brigade Enterprises reports highest-ever quarterly pre-sales, stock surges.
- Angel One gains 7% on robust Q4 earnings, focus on distribution segment.
- Vodafone Idea’s Rs 18,000 Cr FPO opens, targets 4G expansion.
- Shilpa Medicare hits 52-week high on GMP Certification from Ages, Austria.
- Power Grid surges 4% on winning transmission system projects in Rajasthan, Gujarat.
- JSW Energy rallies 3% after subsidiary gets nod for recovery from TN discom.
- Sunteck Realty’s share price rises on strong Q4 pre-sales growth.
- Agri exports rise in March; fruits, vegetables, spices up, oilmeals down.
- Jubilant Pharmova hits 52-week high after US FDA classifies Roorkee facility as VAI.
- Paytm gains 2% on customer migration to PSP banks.
- Capital Small Finance Bank revisited for investment post-correction.
- Tesla’s entry into India boosts stocks like Sona BLW, Samvardhana Motherson, among others.
- Nuvama notes India’s potential as a green energy player, citing developments at Kandla port.
- US markets dropped due to slower economic growth and inflation concerns.
- Rising US yields raise worries for global equities, including Indian markets.
- State Bank of India saw gains, forming a bullish pattern.
- Fidelity Emerging Markets fund sold stake in Restaurant Brands Asia.
- Vodafone IPO faced chaos during pre-open session.
- Market rebounded from the day’s low, with PSU banks showing strength.
- PSU shipbuilders like Cochin Shipyard and Mazagon Dock gain up to 5% on strong Q4 expectations.
- Brigade Enterprises gains 2% after announcing a deal to bring InterContinental to Hyderabad.
- Divi’s Labs plans up to Rs 700 crore capacity addition after inking a long-term supply deal.
- MAS Financial Services jumps 7% on robust Q4 earnings, AUM crosses Rs 10,700 crore.
- Axis Bank emerges as the top Nifty gainer with impressive Q4 results.
- Indian Hotels Company poised to capitalize on industry upcycle, plans expansion.
- RITES shares gain on signing MoU for project management consultancy works.
- Bharat Forge jumps 5% after double upgrade from BofA Securities.
- Godrej Consumer stock rises as UBS raises target price by nearly 20%.
- Vodafone Idea stock jumps 25% over FPO price as new shares list on exchanges.
- RVNL declared lowest bidder for Rs 239 crore project, shares gain 2%.
- Syngene CEO projects high single-digit to low double-digit revenue growth for FY25.
- Geojit Financial Services reports on relaxed wheat procurement specifications due to erratic weather.
- Hindustan Unilever faces weak demand and competitive intensity, particularly awaiting rural market recovery.
- Rallis India’s new CEO faces challenges of subdued revenue growth and sagging profit margins.
- Tata Consumer’s premium valuation may limit upside despite growth prospects from premium products and merger synergies.
- Hindustan Unilever rebrands Horlicks as a ‘functional nutritional drink’ after regulatory scrutiny.
- Kotak Mahindra Bank shares plummet 10% on RBI curbs, impacting growth projections.
- Canada Pension Investment Board sells a stake in Delhivery in bulk deals.
- NSE excludes Brightcom Group and Ujjivan Financial Services from several Nifty indices.
- Syngene International reports a 6% increase in net profit despite an 8% revenue decline.
- Bajaj Finance’s Q4 preview suggests strong AUM growth but margin dent due to cost of funds.
- United Breweries rockets 10% on solid Q4 revenue growth driven by volume and price mix.
- India VIX hits 5-month low on geopolitical calm
- Telecom stocks dip as Airtel denies talks on Vodafone UK’s Indus Towers stake
- JNK India confident on revenue, dismisses debt concerns.
- Remus Pharma surges 20% on bonus share declaration
- Zydus Life drops 4% after US FDA’s observations for Vadodara unit
Weekly News Digest
1. Solara Active Pharma Sciences hits 52-week high.
2. Patel Engineering launches QIP at Rs 59.50 per share.
3. Quant Small Cap Fund picks up stake in Indraprastha Medical.
4. Dr Lal Path Labs, Metropolis face competition from new-age diagnostic rivals.
5. Persistent Systems shares drop 9% on Q4 miss.
2. Patel Engineering launches QIP at Rs 59.50 per share.
3. Quant Small Cap Fund picks up stake in Indraprastha Medical.
4. Dr Lal Path Labs, Metropolis face competition from new-age diagnostic rivals.
5. Persistent Systems shares drop 9% on Q4 miss.
